© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Fresenius SE & Co. KGaA (FSNUY) stock declined over -0.94%, trading at $13.70 on OTC, down from the previous close of $13.83. The stock opened at $13.75, fluctuating between $13.64 and $13.75 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | 13.73 | 13.78 | 13.61 | 13.70 | 164.79K |
| Aug 13, 2026 | 13.80 | 13.95 | 13.72 | 13.80 | 966.51K |
| Aug 12, 2026 | 13.48 | 13.66 | 13.48 | 13.64 | 634.67K |
| Aug 11, 2026 | 13.72 | 13.72 | 13.52 | 13.56 | 52.97K |
| Aug 10, 2026 | 13.62 | 13.69 | 13.50 | 13.57 | 59.16K |
| Aug 07, 2026 | 13.60 | 13.66 | 13.58 | 13.66 | 50.24K |
| Aug 06, 2026 | 13.78 | 13.78 | 13.46 | 13.54 | 55.41K |
| Aug 05, 2026 | 13.60 | 13.65 | 13.43 | 13.56 | 45.03K |
| Aug 04, 2026 | 12.83 | 12.93 | 12.81 | 12.86 | 127.13K |
| Aug 03, 2026 | 13.03 | 13.13 | 12.92 | 13.13 | 60.41K |
| Jul 31, 2026 | 12.98 | 12.98 | 12.86 | 12.88 | 56.4K |
| Jul 30, 2026 | 12.92 | 13.09 | 12.90 | 12.99 | 56.3K |
| Jul 29, 2026 | 12.86 | 12.94 | 12.71 | 12.78 | 56.79K |
| Jul 28, 2026 | 12.61 | 12.75 | 12.61 | 12.71 | 117.03K |
| Jul 27, 2026 | 12.70 | 12.72 | 12.63 | 12.65 | 272.48K |
| Jul 24, 2026 | 12.42 | 12.59 | 12.41 | 12.48 | 1.26M |
| Jul 23, 2026 | 12.21 | 12.44 | 12.02 | 12.30 | 836.15K |
| Jul 22, 2026 | 12.49 | 12.75 | 12.46 | 12.46 | 58.43K |
| Jul 21, 2026 | 12.38 | 12.85 | 12.38 | 12.63 | 181.51K |
| Jul 20, 2026 | 12.23 | 12.39 | 12.22 | 12.33 | 286.76K |
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
| Employees | 178394 |
| Beta | 0.83 |
| Sales or Revenue | $22.30B |
| 5Y Sales Change% | -0.343% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |